A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2006
10/05/2006	US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/05/2006	US20060223869 Dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole in combination with a second active substance selected from D1, D2, D3, and D4 receptor agonists, anorectics, lipase inhibitors and sympathomimetics; for treating overweight or obesity or type 2 diabetes
10/05/2006	US20060223865 Therapeutic combination
10/05/2006	US20060223836 New phenylalanine derivatives
10/05/2006	US20060223828 Substituted chroman derivatives
10/05/2006	US20060223826 Indole derivatives as somatostatin agonists or antagonists
10/05/2006	US20060223819 Quinoline Derivatives as NK-3 Antagonists
10/05/2006	US20060223811 Triglycerine depressant composition
10/05/2006	US20060223803 Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome
10/05/2006	US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics
10/05/2006	US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid
10/05/2006	US20060222620 Composition for pharmaceutical or dietetic use for combating hair loss
10/05/2006	DE202005020766U1 Neue Kristallformen von Atorvastatin-Hemi-Calcium New crystal forms of atorvastatin hemi-calcium
10/05/2006	DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals
10/05/2006	DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments
10/05/2006	CA2603450A1 Compositions for oral transmucosal delivery of metformin
10/05/2006	CA2602250A1 Pyridine derivatives useful as inhibitors of pkc-theta
10/05/2006	CA2601794A1 Methods of treatment utilizing certain melatonin derivatives
10/05/2006	CA2582230A1 A novel process for preparation of substantially pure glimepiride
10/05/2006	CA2504447A1 Diet food product
10/04/2006	EP1707572A2 Sterol compositions from pulping soap
10/04/2006	EP1707567A1 Novel fused-ring compound
10/04/2006	EP1707566A1 Deazapurines and uses thereof
10/04/2006	EP1707564A2 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
10/04/2006	EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
10/04/2006	EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity
10/04/2006	EP1707195A1 Retinoic acid-containing remedy for diabetes
10/04/2006	EP1706413A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases
10/04/2006	EP1706388A1 Therapeutic agents ii
10/04/2006	EP1706386A1 Bicyclic derivatives as ppar modulators
10/04/2006	EP1706384A1 Therapeutic agents i
10/04/2006	EP1706152A2 Particle-induced ghrelin immune response
10/04/2006	EP1706128A1 Pharmaceutical compositions and methods for insulin treatment
10/04/2006	EP1706124A1 A composition comprising the extract of cucurbitaceae family plant or the purified extract isolated therefrom having anti-adipogenic and anti-obesity activity
10/04/2006	EP1706114A1 Chemical inhibitors of soluble adenylyl cyclase (sac)
10/04/2006	EP1706112A2 Methods of treating an inflammatory-related disease
10/04/2006	EP1706108A1 Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
10/04/2006	EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide
10/04/2006	EP1513840B1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
10/04/2006	EP1482951B1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
10/04/2006	EP1420799B1 Use of atazanavir in hiv therapy
10/04/2006	EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors
10/04/2006	EP1406900B1 Novel compounds, their preparation and use
10/04/2006	EP1395128B1 Acid controlled viscosity fibre system and uses thereof
10/04/2006	EP1385840B1 Sulfonamides
10/04/2006	EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006	EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
10/04/2006	EP1354602B1 Medicinal compositions containing diuretic and insulin resistance-improving agent
10/04/2006	EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
10/04/2006	EP1248640B1 Preparation and xenotransplantation of porcine islets
10/04/2006	EP1143931B1 Pulmonary drug delivery
10/04/2006	EP0977873B1 Method for cleavage of fusion proteins
10/04/2006	CN1842536A Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia
10/04/2006	CN1842524A 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
10/04/2006	CN1842522A Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
10/04/2006	CN1842520A 1h-imidazole derivatives as cannabinoid receptor modulators
10/04/2006	CN1842330A Glycosidase inhibitors and methods of synthesizing same
10/04/2006	CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
10/04/2006	CN1840527A Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
10/04/2006	CN1840195A A synergistic pharmaceutical combination for the prevention or treatment of diabetes
10/04/2006	CN1840176A Sublingual tablet of natural hirudin
10/04/2006	CN1840171A Nutrition liquid for chronic nephropathy and preparation method thereof
10/04/2006	CN1840153A Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof
10/04/2006	CN1840123A Medicinal tea for treating diabetes
10/04/2006	CN1840103A Novel process for extracting natural tartaric acid
10/04/2006	CN1840081A Diabetes-treating tablet and preparation method thereof
10/04/2006	CN1840075A Diabetes-treating capsule and preparation method thereof
10/04/2006	CN1840074A Tablet with lily and spirulina
10/04/2006	CN1840073A Application of 'Wang Shi Bao Chi Wan' in preparation of medicine for treating hyperlipemia, high blood viscosity syndrome, high blood sugar and hypertension
10/04/2006	CN1840066A Medicine for treating diabetes and its preparing process
10/04/2006	CN1840049A Medicine for treating diabetic nephropathy
10/04/2006	CN1840038A Application of H. seniavinii Maxim. in preparation of fat-reducing medicine
10/04/2006	CN1840009A Method for preparing blood fat-reducing product
10/04/2006	CN1840000A Nutrition oral liquor
10/04/2006	CN1839978A Fat-reducing face-beautifying medicine
10/04/2006	CN1839956A Pharmaceutical composition containing curcumin and its formulation
10/04/2006	CN1839955A Capsule for protecting heart and its preparing process
10/04/2006	CN1839944A Granular composition for reducing blood fat and process for producing the same
10/04/2006	CN1839939A Method for extracting alpha- glucosidase inhibitor from traditional Chinese cinnamomum cassia
10/04/2006	CN1839900A Use of chestnut flower extract in pharmacy
10/04/2006	CN1839891A Sea-tangle oral liquid with low sugar and rich iodine and its preparation method
10/04/2006	CN1839882A Medicament composition for treating tinea pedis and tinea corporis
10/04/2006	CN1839874A Water-soluble vitamin formulation containing sodium calcium ethylene diamine tetracetate for injection and its preparation method
10/04/2006	CN1839873A Pharmaceutically active uridine esters
10/04/2006	CN1839869A Use of molo glycoside in alpha-glucosaccharase inhibitor
10/04/2006	CN1839866A Medicinal composition containing breviscapine
10/04/2006	CN1839863A Diabetes-treating pharmaceutical compositions and its preparing method and uses
10/04/2006	CN1839852A Zoledronic acid freeze dried powder injection and its preparing method
10/04/2006	CN1839823A Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
10/04/2006	CN1839819A Medicinal composition containing tanshinone and its preparation process and usage
10/04/2006	CN1839814A Methionine enteric casing preparation and its preparing process
10/04/2006	CN1839813A Composite amino acid freeze dried powder injection and its preparation process
10/04/2006	CN1839812A Glibenclamide solid dispersion agent , oral single-ingredient or compound formulation and its preparation method
10/04/2006	CN1277925C Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof
10/04/2006	CN1277828C Piperzine derivative
10/04/2006	CN1277826C Huivastatin, its synthesizing method and preparation with huivastatin as materials
10/04/2006	CN1277824C Piperazine derivatives
10/04/2006	CN1277565C Nutritious drugs for improving children's intelligence
10/04/2006	CN1277564C Blood fat-decreasing weight-reducing kaladana capsule and its preparation process
10/04/2006	CN1277546C Chinese medicine extract for treating fatty liver, obesity and its preparation method

1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 1298